Faron Pharmaceuticals Oy (FARN) Stock Chart & Stock Price History GBX 198.76 +6.26 (+3.25%) As of 11:39 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Faron Pharmaceuticals Oy Stock Price Performance 5 Day Performance+0.38%1 Month Performance-7.55%3 Month Performance+18.59%6 Month Performance+20.46%Year-To-Date Performance-3.98%1 Year Performance+32.51% Receive FARN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Faron Pharmaceuticals Oy and its competitors with MarketBeat's FREE daily newsletter. Email Address FARN Stock Chart for Friday, May, 2, 2025 FARN Chart by TradingView Faron Pharmaceuticals Oy Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025GBX 194.45GBX 198.76+2.22%GBX 202.90GBX 18619,249 shs£266.84 million05/01/2025GBX 210GBX 194.45-7.40%GBX 195.75GBX 19110,110 shs£261.05 million04/30/2025GBX 200GBX 210+5.00%GBX 210GBX 19736,705 shs£281.93 million04/29/2025GBX 196GBX 200+2.04%GBX 203GBX 20020,913 shs£268.50 million04/28/2025GBX 198GBX 196-1.01%GBX 207GBX 1966,826 shs£263.13 million04/25/2025GBX 200.75GBX 198-1.37%GBX 205GBX 195.509,855 shs£265.82 million04/24/2025GBX 211GBX 200.75-4.86%GBX 206.90GBX 200.757,150 shs£269.51 million04/23/2025GBX 213.60GBX 211-1.22%GBX 211GBX 20552,423 shs£283.27 million04/22/2025GBX 212.40GBX 213.60+0.56%GBX 213.60GBX 20158,215 shs£286.76 million04/21/2025GBX 212.40GBX 212.40GBX 213GBX 202415,948 shs£285.15 million Get the Latest News and Ratings for FARN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Faron Pharmaceuticals Oy and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025GBX 212.40GBX 212.40GBX 213GBX 202415,948 shs£285.15 million04/17/2025GBX 197GBX 212.40+7.82%GBX 213GBX 202415,948 shs£285.15 million04/16/2025GBX 235GBX 197-16.17%GBX 310GBX 1902.57 million shs£264.48 million04/15/2025GBX 250GBX 235-6.00%GBX 265GBX 230167,722 shs£315.49 million04/14/2025GBX 239GBX 250+4.60%GBX 250GBX 233.3545,377 shs£335.63 million04/11/2025GBX 230GBX 239+3.91%GBX 240GBX 23121,091 shs£320.86 million04/10/2025GBX 222GBX 230+3.60%GBX 230GBX 22037,023 shs£308.78 million04/09/2025GBX 223GBX 222-0.45%GBX 234GBX 22046,366 shs£298.04 million04/09/2025GBX 223GBX 222-0.45%GBX 234GBX 22046,366 shs£298.04 million04/08/2025GBX 215GBX 223+3.72%GBX 232.55GBX 21546,064 shs£299.38 million04/08/2025GBX 215GBX 223+3.72%GBX 232.55GBX 21546,064 shs£299.38 million04/07/2025GBX 208GBX 215+3.37%GBX 220GBX 196.6756,125 shs£288.64 million04/04/2025GBX 208.25GBX 208-0.12%GBX 218.50GBX 20543,451 shs£279.24 million04/03/2025GBX 215GBX 208.25-3.14%GBX 216GBX 199.8068,155 shs£279.58 million04/02/2025GBX 207.60GBX 215+3.56%GBX 216GBX 2088,616 shs£288.64 million04/01/2025GBX 212GBX 207.60-2.08%GBX 214GBX 20410,994 shs£278.71 million Related Companies Genus Stock Price Chart PureTech Health Stock Price Chart Oxford Biomedica Stock Price Chart 4basebio Stock Price Chart Bioventix Stock Price Chart Avacta Group Stock Price Chart hVIVO Stock Price Chart Scancell Stock Price Chart Ondine Biomedical Stock Price Chart SkinBioTherapeutics Stock Price Chart Receive FARN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Faron Pharmaceuticals Oy and its competitors with MarketBeat's FREE daily newsletter. This page (LON:FARN) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Faron Pharmaceuticals Oy Please log in to your account or sign up in order to add this asset to your watchlist. Share Faron Pharmaceuticals Oy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.